As a result of the discovery that mutations in BRCA1 and BRCA2 predispose to development and aggressiveness of prostate cancer,35 germline testing for BRCA1, BRCA2, and other cancer predisposition syndromes such as Lynch Syndrome is likely to gain more prominence. Here, BRCA2 is linked to prostate carcinoma.